Table 1 Primary objective and outcome
Primary objective and outcome measure | ||
|---|---|---|
Objective | Outcome measure | Time point(s) of evaluation |
To compare 30-day all-cause mortality of 5 to 14 days ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to ESBL or AmpC-producing Enterobacterales | Difference in proportion of those dead in each group | 30 days after randomisation |